Background Patients with lung cancers may have disproportionately severe coronavirus
disease 2019 (COVID-19) outcomes. Understanding the patient-specific and cancer-specific …

Background We conducted the first trial of neoadjuvant PD-1 blockade in resectable non-small
cell lung cancer (NSCLC), finding nivolumab monotherapy to be safe and feasible with …

The endemic, dendrobatid frog, Colostethus beebei, lived and bred only in water-filled axils
of a giant terrestrial bromeliad, Brocchinia micrantha, at Kaieteur National Park, Guyana, …

Importance Real-world data sets that combine clinical and genomic data may be subject to
left truncation (when potential study participants are not included because they have already …

Background There is a rising prevalence of multimorbidity, particularly in older patients, and
a need for evidence-based medicines management interventions for this population. The …

Purpose: MET tyrosine kinase inhibitors (TKIs) can achieve modest clinical outcomes in
MET exon 14–altered lung cancers, likely secondary to primary resistance. Mechanisms of …

Pathobionts employ unique metabolic adaptation mechanisms to maximize their growth in
disease conditions. Adherent-invasive Escherichia coli (AIEC), a pathobiont enriched in the …

Purpose: Loss of alveolar bone in the anterior maxilla may preclude implant placement or
compromise positioning and thus diminish the final esthetic result of the restoration. Bone …

Background Multimorbidity, defined as the presence of at least two chronic conditions,
becomes increasingly common in older people and is associated with poorer health outcomes …

Importance Contemporary observational cancer research requires associating genomic
biomarkers with reproducible end points; overall survival (OS) is a key end point, but …